Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Mar 23, 2020 7:36pm

168 Views

Post# 30839814

Hope Pandora is right and we plumb 10 cents

That would translate into a CDN$10M valuation, net of an estimated $10M in cash on the balance sheet.

It's more rediculous in Yankee dollars: US$7M.

I challenge everyone here to find a promising oncology play in PH2 trials that is worth as little as TLT.

If we get to a dime, I will double my position to 2M+ shares.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal